2 Background: Growing evidence indicates that prolonged sedentary behaviour increases the 3 risk of several chronic health conditions and all-cause mortality. Sedentary behaviour is 4 prevalent among adults in the United Kingdom (UK). Quantifying the costs associated with 5 sedentary behaviour is an important step in the development of public health policy.
INTRODUCTION 1
Adults in the United Kingdom (UK) have become increasingly sedentary as modern 2 technology has changed everyday life. [1] Sedentary behaviour is distinct from physical 3 inactivity and refers to sitting or lying while expending low amounts of energy (≤1.5 4 metabolic equivalents [METs] ).[2] National guidelines recommend minimising time spent 5 sedentary[3] without specifying how many hours/day of sitting might be harmful. A recent 6 meta-analysis reported that spending 6-8 hours/day sedentary increases future risk of all-7 cause and cardiovascular disease (CVD) . [4] This study defined sedentary behaviour as 8 spending at least six hours of waking time sedentary. Thirty percent of adults in the UK are 9 sedentary for a least six hours/day during the week, which rises to 37% at the weekend. [5] 10 Consequently, many individuals in the UK are at greater risk of chronic disease.
11
Sedentary behaviour is an established risk factor for several non-communicable diseases. 12 Strong evidence suggests that high levels of sitting time lead to increased risk of CVD, type 2 13 diabetes, and all-cause mortality (risk of mortality from all causes, not only those mentioned 14 here). [6] Additionally, moderate evidence indicates an increased risk of colon, endometrial, 15 and lung cancer. [6] These diseases all contribute considerably to morbidity and mortality in 16 the UK. Thus, addressing the problem of sedentary behaviour could potentially reduce the 17 burden of disease. 18 Awareness of the economic burden of sedentary behaviour could inform and motivate 19 policymakers to address this risk factor. Estimates of the cost impacts allow decision makers 20 to prioritise funding and make an economic argument for investment in prevention. Estimates 21 for the financial impact of many lifestyle risk factors in the UK are available, such as obesity, 22 smoking, and physical inactivity, [7, 8] however none exist thus far for sedentary 23 behaviour. As a result, this study aims to estimate the direct healthcare costs of prolonged 24 sedentary behaviour in the UK.
25

METHODS
26
Costs were estimated from a healthcare payer perspective (UK National Health Service
27
[NHS]) using a prevalence-based and population attributable fraction-(PAF) approach, We selected the most suitable meta-analyses cited in a recent report of the relationship 1 between sedentary behaviour and health [6] in order to extract the relative risks (RRs).
2
Appropriate studies employed a prospective design, non-diseased participants at baseline, and 3 adjusted for levels of physical activity in their statistical model. Furthermore, the researchers 4 had investigated the association by comparing the most sedentary individuals with the least 5 sedentary, and we preferred studies which had used sedentary time as an exposure. Two 6 studies were appropriate for the outcome of CVD [19, 21] : we chose the more recent meta-7 analysis by Pandey et al. as it had included three additional applicable studies. After 8 examining data from the primary studies, we excluded those that did not meet the exact 9 criteria above and repooled the risk estimate using Review Manager (RevMan version 5.3).
10
Estimating the extent of sedentary behaviour in the UK population 11 The Health Survey for England (HSE) 2012 [5] reported that 30% of adults in England spent 12 at least six hours/day sedentary on weekdays, and 37% of adults at the weekend. We used 13 these figures to estimate the percentage of UK adults who are sedentary on any given day of 14 the week.
15
The PAF formula we have used requires the prevalence of sedentary behaviour at baseline in 16 those who went on to become cases (i.e., experiencing the adverse outcome). This 17 information is not readily available. Therefore, we calculated prevalence "adjustment 18 factors"[9] using data from cohort studies. We searched for cohort studies on Pubmed that 19 fitted the same criteria mentioned in the previous section and had specifically measured and 20 reported sedentary behaviour for the total population and for cases only at baseline. We 21 preferred European-based studies and larger studies with longer follow-up times to give more 22 reliable adjustment factors. The proportion of cases in the highest reported category of 23 sedentary behaviour was divided by the proportion of people at baseline in the highest 24 category to produce an adjustment factor. For example, Stamatakis et al. [10] reported that 25 34.1% of all study participants and 38.3% of diabetes cases were sedentary at baseline. The 26 adjustment factor was 1.12 (38.3/34.1). We then multiplied the adjustment factor by the 27 prevalence of sedentary behaviour in the general population in order to estimate the 28 additional prevalence among cases. Calculating costs attributable to sedentary behaviour 9 We multiplied the adjusted PAFs and their 95% CIs by the total disease expenditure to 10 estimate the NHS costs attributable to sedentary behaviour in the UK. Since the timeframe 11 for this analysis is one year, discounting was unnecessary.
12
Thirty percent of Europeans with type 2 diabetes are also affected by CVD.
[17] Therefore,
13
30% of the type 2 diabetes expenditure attributable to sedentary behaviour was subtracted 14 from the total costs to adjust for double-counting caused by this co-morbidity. This is 15 consistent with the approach used by Ding et al. [7] 16
Estimating the avoidable deaths due to sedentary behaviour 17 In addition, we multiplied the PAF for all-cause mortality by the total number of UK deaths 18 in 2016 to estimate the number of deaths that would have been avoided if prolonged 19 sedentary behaviour was completely eliminated. As complete elimination is unrealistic, the 20 number of avoidable deaths was also estimated for 10%, 30%, and 50% potential reductions 21 in the proportion of sedentary individuals (i.e., sedentary ≥6 hours/day).
22
RESULTS
23
The health outcomes that we considered most relevant for this analysis were type 2 diabetes, Individual healthcare budgets were not available for these years and so costs had to be 16 inflated. After adjustment for double-counting, the NHS costs attributable to sedentary behaviour is 2 £677 million. An alternative method [7] was also used as a sensitivity analysis. A meta-3 analysis reported the RR of having CVD as being 206% higher for people with type 2 4 diabetes compared to those without type 2 diabetes.
[28] Based on the prevalence of CVD in 5 the general population (4.28%, as reported by the British Heart Foundation), [29] we estimate 6 that 8.82% of people with type 2 diabetes have CVD. After subtracting 8.82% of type 2 7 diabetes expenditure, the total costs attributable to sedentary behaviour were £737 million.
8
After an additional sensitivity analysis which excluded diseases for which only moderate 9 evidence of an association was available, the total costs attributable to sedentary behaviour 10 were £706 million (£600, £807 million), i.e., approximately eight per cent lower. The small 11 change is due to the much lower incidence and prevalence of the individual cancers in 12 comparison to CVD and type 2 diabetes expenditure. The total costs presented are likely to be a conservative estimate of the true burden of the methodology (using a Monte-Carlo micro-simulation) was somewhat different. Thus, it is 6 difficult to compare these estimates. Nonetheless, it is interesting to note that the PAFs for 7 type 2 diabetes, CVD and all-cause mortality are of the same order of magnitude (i.e., type 2 8 diabetes > all-cause mortality > CVD). The PAFs for CVD are similar (5% [95% CI: 1%, 9 8%] from Patterson vs. 4.9% (95% CI: 1.8%, 7.9%) in the present study). This indicates that 10 although the studies differ in their definition of sedentary behaviour and in the methods used, 11 there is considerable agreement in the observed pattern of the relationships.
12
This study had several strengths. We have calculated PAFs for sedentary behaviour in the UK 13 using the best data available, and we have included all conditions reported as having [33] Importantly, all extracted RRs had been adjusted for physical activity. We provided 17 uncertainty limits in the form of 95% CIs for the PAFs and the subsequent cost estimates.
18
Finally, we subtracted a proportion of costs to account for the strong likelihood of double-19 counting due to co-morbidities. 20 However, the study was limited by the evidence available for sedentary behaviour and health 21 outcomes. We included a non-European study [37] in order to estimate the prevalence of 22 sedentary behaviour in lung cancer cases, which may not fully reflect a UK population.
23
Individual studies included in the meta-analyses which were used in this analysis varied in will need to be updated as further evidence on sedentary behaviour emerges.
13
There are several barriers that cause a gap between evidence and practice. Evidence may be 14 non-existent or arrive too late for policymakers. They may prefer uncomplicated papers and a 15 wide range of evidence to inform their decisions. [40] We have been explicit about the 16 strengths and weakness of this straightforward cost estimation for the benefit of other 17 academics and policymakers. We hope that these results can be easily understood and Health Outcomes: An Overview of Systematic Reviews. PLoS One. 
